Adherence to guidelines by french psychiatrists in their real world of clinical practice

Journal of Nervous and Mental Disease

Volumn 199, Issue 4, 2011, Pages 239-243

  Samalin, Ludovic ^a   Guillaume, Sebastien ^b   Auclair, Candy ^a   Llorca, Pierre Michel ^c  

^a UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^b MONTPELLIER UNIVERSITY HOSPITAL   (France)

^c NONE

Author keywords

Bipolar disorder; clinical practice; guideline adherence; guidelines

Indexed keywords

AMISULPRIDE; ARIPIPRAZOLE; CARBAMAZEPINE; CYAMEMAZINE; HALOPERIDOL; LITHIUM; LOXAPINE; OLANZAPINE; RISPERIDONE; VALPROIC ACID; VALPROMIDE;

ADULT; AGED; ARTICLE; BIPOLAR DISORDER; CLINICAL PRACTICE; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MANIA; MEDICAL DECISION MAKING; OBSERVATIONAL STUDY; PATIENT COMPLIANCE; PERSONAL EXPERIENCE; PRACTICE GUIDELINE; PSYCHIATRIC TREATMENT; PSYCHIATRIST; QUESTIONNAIRE; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; AGE FACTORS; AGED; ANTIMANIC AGENTS; BIPOLAR DISORDER; FEMALE; FRANCE; GUIDELINE ADHERENCE; HUMANS; LITHIUM COMPOUNDS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; PSYCHIATRY; QUESTIONNAIRES; VALPROIC ACID;

EID: 79954556062     PISSN: 00223018     EISSN: None     Source Type: Journal    
DOI: 10.1097/NMD.0b013e3182125d4c     Document Type: Article

References (24)

1. APA (2002) American Psychiatric Association: Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry 159:1-50.
2. Bauer MS (2002) A review of quantitative studies of adherence to mental health clinical practice guidelines. Harv Rev Psychiatry. 10:138-153. (Pubitemid 34553138)
3. Bauer MS, Biswas K, Kilbourne AM (2009) Enhancing multiyear guideline concordance for bipolar disorder through collaborative care. Am J Psychiatry. 166:1244-1250.
4. Fajutrao L, Locklear J, Priaulx J, Heyes A (2009) A systematic review of the evidence of the burden of bipolar disorder in Europe. Clin Pract Epidemiol Ment Health. 5:3.
5. Fountoulakis KN, Vieta E, Sanchez-Moreno J, Kaprinis SG, Goikolea JM, Kaprinis GS (2005) Treatment guidelines for bipolar disorder: A critical review. J Affect Disord. 86:1-10. (Pubitemid 40487954)
6. Gilbert DA, Altshuler KZ, Rago WV, Shon SP, Crismon ML, Toprac MG, Rush AJ (1998) Texas Medication Algorithm Project: Definitions, rationale and methods to develop medication algorithms. J Clin Psychiatry. 59:345-351. (Pubitemid 28373100)
7. Glikman J, Pazart L, Casadebaig F, Philippe A, Lachaux B, Kovess V, Cochet Faurisson C, Terra JL, Durocher A (1999) The study of the impact of the consensus conference Strategies for long-term therapy of patients with schizophrenia. Encephale. 25:558-568. (Pubitemid 30046243)
8. Goodwin GM (2003) Evidence-based guidelines for treating bipolar disorder: Recommendations from the British association for psychopharmacology. J Psychopharmacol. 17:149 -173; discussion 147.
9. Goodwin GM (2009) Evidence-based guidelines for treating bipolar disorder: Recommendations from the British association for psychopharmacology. J Psychopharmacol. 23:346-388.
10. Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Moller HJ, Kasper S (2009) The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the biological treatment of bipolar disorders: Update 2009 on the treatment of acute mania. World J Biol Psychiatry. 10:85-116.
11. Hamann J, Langer B, Leucht S, Busch R, Kissling W (2004) Medical decision making in antipsychotic drug choice for schizophrenia. Am J Psychiatry. 161:1301-1304. (Pubitemid 38859185)
12. HAS (2009) Haute Autorité de Santé. Troubles Bipolaires. Guide Médecin-AL23. Available at: www.has-sante.fr, 1-74.
13. Kilbane EJ, Gokbayrak NS, Galynker I, Cohen L, Tross S (2009) A review of panic and suicide in bipolar disorder: Does comorbidity increase risk? J Affect Disord. 115:1-10.
14. Licht RW, Vestergaard P, Kessing LV, Larsen JK, Thomsen PH (2003) Psychopharmacological treatment with lithium and antiepileptic drugs: Suggested guidelines from the Danish Psychiatric Association and the Child and Adolescent Psychiatric Association in Denmark. Acta Psychiatr Scand Suppl. 419:1-22. (Pubitemid 37297197)
15. Lim PZ, Tunis SL, Edell WS, Jensik SE, Tohen M (2001) Medication prescribing patterns for patients with bipolar I disorder in hospital settings: Adherence to published practice guidelines. Bipolar Disord. 3:165-173. (Pubitemid 32842741)
16. Malhi GS, Adams D (2009) Are guidelines in need of CPR? The development of clinical practice recommendations (CPR). Acta Psychiatr Scand Suppl. 439: 5-7.
17. National Institute for Health and Clinical Excellence (2006) Bipolar disorder: The management of bipolar disorder in adults, children and adolescents, in primary and secondary care. National Institute for Health and Clinical Excellence. UK. Available at: www.nice.org.uk.
18. Perlis RH (2007) Use of treatment guidelines in clinical decision making in bipolar disorder: A pilot survey of clinicians. Curr Med Res Opin. 23:467-475. (Pubitemid 46456895)
19. Sanchez-Moreno J, Martinez-Aran A, Tabarés-Seisdedos R, Torrent C, Vieta E, Ayuso-Mateos JL (2009) Functioning and disability in bipolar disorder: An extensive review. Psychother Psychosom. 78:285-297.
20. Smith TE, Levine SB, Hampel J (2008) A Successful Effort to Improve Adherence to Treatment Guidelines for Bipolar Disorder. Harv Rev Psychiatry. 16:210-213. (Pubitemid 351883194)
21. Vestergaard P (2004) Guidelines for maintenance treatment of bipolar disorder: Are there discrepancies between European and North American recommendations? Bipolar Disorders. 6:519-522. (Pubitemid 39562419)
22. Vieta E, Morralla E (2007) 2.e. 017 Bipolar disorder treatment guidelines followed by Spanish psychiatrists. GAMEB Study. European Neuropsychopharmacol. 17:S385-S386.
23. Vieta E, Nolen WA, Grunze H, Licht RW, Goodwin G (2005) A European perspective on the Canadian guidelines for bipolar disorder. Bipolar Disord. 7(suppl. 3):73-76. (Pubitemid 41065250)
24. Yatham L (2009) 04.04 CANMAT/ISBD collaborative update of guidelines for bipolar disorder. European Neuropsychopharmacol. 19:S222-S222.